These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22455388)

  • 1. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells.
    Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C
    Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
    Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R
    Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
    De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
    Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Lam YM; Chan YF; Chan LC; Ng RK
    Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
    Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid.
    Papa L; Djedaini M; Hoffman R
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
    Bug G; Gül H; Schwarz K; Pfeifer H; Kampfmann M; Zheng X; Beissert T; Boehrer S; Hoelzer D; Ottmann OG; Ruthardt M
    Cancer Res; 2005 Apr; 65(7):2537-41. PubMed ID: 15805245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.
    Andrade PZ; da Silva CL; dos Santos F; Almeida-Porada G; Cabral JM
    J Cell Biochem; 2011 Jul; 112(7):1822-31. PubMed ID: 21400571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
    Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
    Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells.
    Burba I; Colombo GI; Staszewsky LI; De Simone M; Devanna P; Nanni S; Avitabile D; Molla F; Cosentino S; Russo I; De Angelis N; Soldo A; Biondi A; Gambini E; Gaetano C; Farsetti A; Pompilio G; Latini R; Capogrossi MC; Pesce M
    PLoS One; 2011; 6(7):e22158. PubMed ID: 21789227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histone Deacetylase Inhibitors in the in Vitro Expansion of Hematopoietic Stem Cells].
    Chen M; Zhuang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):109-115. PubMed ID: 33663671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down.
    Liu YX; Dong X; Gong F; Su N; Li SB; Zhang HT; Liu JL; Xue JH; Ji SP; Zhang ZW
    PLoS One; 2015; 10(8):e0135259. PubMed ID: 26252772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
    da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
    J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells.
    Oodi A; Noruzinia M; Habibi Roudkenar M; Nikougoftar M; Soltanpour MS; Khorshidfar M; Amirizadeh N
    Hematology; 2012 Nov; 17(6):334-40. PubMed ID: 22989929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
    Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
    Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent.
    Mishima S; Nagai A; Abdullah S; Matsuda C; Taketani T; Kumakura S; Shibata H; Ishikura H; Kim SU; Masuda J
    Eur J Haematol; 2010 Jun; 84(6):538-46. PubMed ID: 20088916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.